82 related articles for article (PubMed ID: 20700647)
1. Disseminated tumor cells: the method is the message.
Park JW
Breast Cancer Res Treat; 2011 Feb; 125(3):739-40. PubMed ID: 20700647
[No Abstract] [Full Text] [Related]
2. Circulating and disseminated tumor cells.
Braun S; Naume B
J Clin Oncol; 2005 Mar; 23(8):1623-6. PubMed ID: 15755968
[No Abstract] [Full Text] [Related]
3. Current status in human breast cancer micrometastasis.
Alix-Panabières C; Müller V; Pantel K
Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
[TBL] [Abstract][Full Text] [Related]
4. Rating of isolated disseminated tumor cells in bone marrow in comparison with other factors of prognosis in breast carcinoma.
Leinung S; Würl P; Schönfelder A; Weiss CL; Röder I; Schönfelder M
Int J Surg Investig; 2000; 2(3):193-202. PubMed ID: 12678519
[TBL] [Abstract][Full Text] [Related]
5. Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer.
Friel AM; Corcoran C; Crown J; O'Driscoll L
Breast Cancer Res Treat; 2010 Oct; 123(3):613-25. PubMed ID: 20549336
[TBL] [Abstract][Full Text] [Related]
6. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of IGF-1R expression in patients treated with breast-conserving surgery and radiation therapy.
Taunk NK; Goyal S; Moran MS; Yang Q; Parikh R; Haffty BG
Radiother Oncol; 2010 Aug; 96(2):204-8. PubMed ID: 20338651
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer.
Thomas C; Wiesner C; Melchior SW; Schmidt F; Gillitzer R; Thüroff JW; Pfitzenmaier J
BJU Int; 2009 Jul; 104(1):29-34. PubMed ID: 19154451
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity.
Müller V; Stahmann N; Riethdorf S; Rau T; Zabel T; Goetz A; Jänicke F; Pantel K
Clin Cancer Res; 2005 May; 11(10):3678-85. PubMed ID: 15897564
[TBL] [Abstract][Full Text] [Related]
10. [The identification of minimal residual disease in the bone marrow and peripheral blood in neuroblastoma. The prognostic and therapeutic implications].
Faulkner LB; Tamburini A; Tintori V; Paoli A; Tondo A; Bernini G; Medicina D; Brisigotti M; Corrias MV; Scaruffi P; Rosanda C; Lo Piccolo MS; Viscardi E; Milanaccio C; Garaventa A; De Bernardi B
Pediatr Med Chir; 1998; 20(3):175-8. PubMed ID: 9744008
[TBL] [Abstract][Full Text] [Related]
11. Analysis of gene expression as relevant to cancer cells and circulating tumour cells.
Friel AM; Crown J; O'Driscoll L
Methods Mol Biol; 2011; 784():55-75. PubMed ID: 21898213
[TBL] [Abstract][Full Text] [Related]
12. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
13. COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.
Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C
Expert Opin Ther Targets; 2010 Jul; 14(7):655-64. PubMed ID: 20536410
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of disseminated tumor cells in breast cancer.
Slade MJ; Coombes RC
Nat Clin Pract Oncol; 2007 Jan; 4(1):30-41. PubMed ID: 17183354
[TBL] [Abstract][Full Text] [Related]
15. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
Lang JE; Hall CS; Singh B; Lucci A
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
[TBL] [Abstract][Full Text] [Related]
16. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases.
Mimori K; Fukagawa T; Kosaka Y; Ishikawa K; Iwatsuki M; Yokobori T; Hirasaki S; Takatsuno Y; Sakashita H; Ishii H; Sasako M; Mori M
Ann Surg Oncol; 2008 Oct; 15(10):2934-42. PubMed ID: 18661187
[TBL] [Abstract][Full Text] [Related]
17. Molecular assays to predict prognosis of breast cancer.
Paik S
Clin Adv Hematol Oncol; 2007 Sep; 5(9):681-2. PubMed ID: 17982408
[No Abstract] [Full Text] [Related]
18. Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients.
Bartkowiak K; Effenberger KE; Harder S; Andreas A; Buck F; Peter-Katalinic J; Pantel K; Brandt BH
J Proteome Res; 2010 Jun; 9(6):3158-68. PubMed ID: 20423148
[TBL] [Abstract][Full Text] [Related]
19. Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients.
Becker S; Solomayer E; Becker-Pergola G; Wallwiener D; Fehm T
Breast Cancer Res Treat; 2007 Dec; 106(2):239-43. PubMed ID: 17260094
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumour cells in cancer patients: challenges and perspectives.
Pantel K; Alix-Panabières C
Trends Mol Med; 2010 Sep; 16(9):398-406. PubMed ID: 20667783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]